NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-1,415 Cr | ₹-1,033 Cr | ₹-477 Cr | ₹-5.30 Cr | ₹-103 Cr |
What is the latest Cash Flow from Investing Activities ratio of NATCO PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-1,415 Cr |
| Mar2024 | ₹-1,033 Cr |
| Mar2023 | ₹-477 Cr |
| Mar2022 | ₹-5.30 Cr |
| Mar2021 | ₹-103 Cr |
How is Cash Flow from Investing Activities of NATCO PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,415 Cr | Negative | |
| Mar2024 | ₹-1,033 Cr | Negative | |
| Mar2023 | ₹-477 Cr | Negative | |
| Mar2022 | ₹-5.30 Cr | Negative | |
| Mar2021 | ₹-103 Cr | - | |
Compare Cash Flow from Investing Activities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹19,595.3 Cr | 2.2% | 15.2% | 29% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,332.0 Cr | 4.7% | -0.3% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,800.0 Cr | 2.3% | 6.8% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,578.0 Cr | 2.5% | -1.7% | 26.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,075.0 Cr | 11.3% | 7.6% | 12.5% | Stock Analytics | |
| CIPLA | ₹105,662.0 Cr | 5.9% | 7.3% | -14.1% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 2.2% |
15.2% |
29% |
| SENSEX | -3% |
5.8% |
-3.4% |
You may also like the below Video Courses